| Document Date: 2014-03-19 10:00:19
Open Document File Size: 322,89 KBShare Result on Facebook
City Haifa / / Company Pluristem / The Times / / Country Germany / United States / Israel / / Facility Paul Ehrlich Institute / / IndustryTerm manufacturing facility / 3D cell expansion manufacturing platform / stem cell products / downstream equipment / throughput culturing technologies / manufacturing cell therapies / 3D micro-environmental technology / 3D commercial scale cell manufacturing processes / grown using the company’s proprietary 3D micro-environmental technology / / MedicalCondition muscular injuries / gluteal muscle injury / Buerger’s disease / local and systemic inflammatory and ischemic diseases / osteoporosis / aplastic anemia / injuries / / MedicalTreatment hip replacement surgery / cell therapy / / Organization US Food and Drug Administration / FDA / Paul Ehrlich Institute / Centers for Disease Control and Prevention / / Person Wolfgang Rattay / Zami Aberman / / Position chairman and CEO / RT USA LIVE / rt / / Region northern Israel / / Technology drug delivery / cell therapy / 3D micro-environmental technology / stem cells / high-throughput culturing technologies / / URL http /
SocialTag |
Mass production of placenta stem cells gets FDA approval — RT USA